Announcement • Jul 06
Bolak Company Limited (KOSE:A002760) announces an Equity Buyback for KRW 1,500 million worth of its shares. Bolak Company Limited (KOSE:A002760) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,500 million worth of its shares pursuant to a contract with Samsung Securities Co., Ltd. The purpose of the program is stock price stabilization and enhancement of shareholder value through treasury stock cancellation. The program will expire on January 5, 2027. As of July 5, 2026, the company had no shares in treasury within scope available for dividend and had no shares in treasury through other repurchase. Announcement • Feb 24
Bolak Company Limited, Annual General Meeting, Mar 26, 2026 Bolak Company Limited, Annual General Meeting, Mar 26, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 720-37, chorok-ro, yanggam-myeon, gyeonggi-do, hwaseong South Korea Upcoming Dividend • Dec 22
Upcoming dividend of ₩5.00 per share Eligible shareholders must have bought the stock before 29 December 2025. Payment date: 29 April 2026. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%). Reported Earnings • Nov 09
Third quarter 2025 earnings released Third quarter 2025 results: Revenue: ₩25.7b (up 103% from 3Q 2024). Net income: ₩2.07b (up 248% from 3Q 2024). Profit margin: 8.1% (up from 4.7% in 3Q 2024). The increase in margin was driven by higher revenue. Declared Dividend • Nov 08
Dividend of ₩5.00 announced Dividend of ₩5.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 29th April 2026 Dividend yield will be 0.5%, which is lower than the industry average of 1.7%. Sustainability & Growth Announcement • Nov 07
Bolak Company Limited announces Annual dividend, payable on April 29, 2026 Bolak Company Limited announced Annual dividend of KRW 5.0000 per share payable on April 29, 2026, ex-date on December 29, 2025 and record date on December 31, 2025. New Risk • May 20
New major risk - Revenue and earnings growth Earnings have declined by 9.0% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.0% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩65.0b market cap, or US$46.7m). Announcement • Mar 18
Bolak Company Limited, Annual General Meeting, Mar 31, 2025 Bolak Company Limited, Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 720-37, chorok-ro, yanggam-myeon, gyeonggi-do, hwaseong South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩5.00 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 21 April 2025. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%). Reported Earnings • Nov 13
Third quarter 2024 earnings released: EPS: ₩10.00 (vs ₩2.00 in 3Q 2023) Third quarter 2024 results: EPS: ₩10.00 (up from ₩2.00 in 3Q 2023). Revenue: ₩12.6b (up 9.2% from 3Q 2023). Net income: ₩594.2m (up 318% from 3Q 2023). Profit margin: 4.7% (up from 1.2% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 17% per year whereas the company’s share price has fallen by 18% per year. Valuation Update With 7 Day Price Move • Oct 08
Investor sentiment improves as stock rises 31% After last week's 31% share price gain to ₩1,316, the stock trades at a trailing P/E ratio of 64.1x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total loss to shareholders of 35% over the past three years. Reported Earnings • May 19
First quarter 2024 earnings released: EPS: ₩6.00 (vs ₩3.00 in 1Q 2023) First quarter 2024 results: EPS: ₩6.00 (up from ₩3.00 in 1Q 2023). Revenue: ₩11.4b (down 7.2% from 1Q 2023). Net income: ₩345.2m (up 107% from 1Q 2023). Profit margin: 3.0% (up from 1.4% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Upcoming Dividend • Dec 20
Upcoming dividend of ₩7.00 per share at 0.5% yield Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 22 April 2024. Trailing yield: 0.5%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%). Reported Earnings • Nov 15
Third quarter 2023 earnings released: EPS: ₩2.00 (vs ₩19.00 in 3Q 2022) Third quarter 2023 results: EPS: ₩2.00 (down from ₩19.00 in 3Q 2022). Revenue: ₩11.6b (down 6.5% from 3Q 2022). Net income: ₩142.0m (down 88% from 3Q 2022). Profit margin: 1.2% (down from 9.3% in 3Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Reported Earnings • May 16
First quarter 2023 earnings released: EPS: ₩3.00 (vs ₩7.00 in 1Q 2022) First quarter 2023 results: EPS: ₩3.00 (down from ₩7.00 in 1Q 2022). Revenue: ₩12.2b (up 12% from 1Q 2022). Net income: ₩167.2m (down 61% from 1Q 2022). Profit margin: 1.4% (down from 3.9% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improved over the past week After last week's 29% share price gain to ₩2,080, the stock trades at a trailing P/E ratio of 44.7x. Average trailing P/E is 10x in the Chemicals industry in South Korea. Negligible returns to shareholders over past three years. Upcoming Dividend • Dec 21
Inaugural dividend of ₩5.00 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 24 April 2023. The company last paid an ordinary dividend in . The average dividend yield among industry peers is 2.4%. Valuation Update With 7 Day Price Move • Dec 13
Investor sentiment improved over the past week After last week's 25% share price gain to ₩1,880, the stock trades at a trailing P/E ratio of 40.4x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 9.0% over the past three years. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Dec 22
Inaugural dividend of ₩4.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 18 April 2022. The company is not currently making a profit but it is cash flow positive. The company last paid an ordinary dividend in . The average dividend yield among industry peers is 1.5%. Reported Earnings • May 19
First quarter 2021 earnings released: EPS ₩2.00 (vs ₩2.00 in 1Q 2020) The company reported a decent first quarter result with improved earnings and profit margins, although revenues were weaker. First quarter 2021 results: Revenue: ₩8.36b (down 20% from 1Q 2020). Net income: ₩136.5m (up 4.5% from 1Q 2020). Profit margin: 1.6% (up from 1.3% in 1Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 39% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Announcement • Feb 27
Bolak Company Limited, Annual General Meeting, Mar 19, 2021 Bolak Company Limited, Annual General Meeting, Mar 19, 2021, at 09:00 Korea Standard Time. Is New 90 Day High Low • Feb 24
New 90-day low: ₩2,150 The company is down 17% from its price of ₩2,585 on 26 November 2020. The South Korean market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 16% over the same period. Is New 90 Day High Low • Jan 31
New 90-day low: ₩2,175 The company is down 1.0% from its price of ₩2,200 on 02 November 2020. The South Korean market is up 29% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 36% over the same period.